Synapse - Find an Expert

Results (17)

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study

Journal Article

Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
Journal for ImmunoTherapy of Cancer (2023)

Fulltext@MSK | Save

Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer

Conference Paper

Lengel, H. B.; Zheng, J.; Tan, K. S.; Liu, C. C.; Park, B. J.; Rocco, G.; Adusumilli, P. S.; Molena, D.; Yu, H. A.; Riely, G. J.; more...
Mosby Elsevier (2023)

Fulltext@MSK | Save

Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy

Journal Article

Hwang, M.; Canzoniero, J. V.; Rosner, S.; Zhang, G.; White, J. R.; Belcaid, Z.; Cherry, C.; Balan, A.; Pereira, G.; Curry, A.; more...
Journal for ImmunoTherapy of Cancer (2022)

Fulltext@MSK | Save

Clinical outcomes, local–regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab

Journal Article

Offin, M.; Shaverdian, N.; Rimner, A.; Lobaugh, S.; Shepherd, A. F.; Simone, C. B. 2nd; Gelblum, D. Y.; Wu, A. J.; Lee, N.; Kris, M. G.; more...
Radiotherapy and Oncology (2020)

Fulltext@MSK | Save

IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens after neoadjuvant therapy

Review

Travis, W. D.; Dacic, S.; Wistuba, I.; Sholl, L.; Adusumilli, P.; Bubendorf, L.; Bunn, P.; Cascone, T.; Chaft, J.; Chen, G.; more...
Journal of Thoracic Oncology (2020)

Fulltext@MSK | Save

KEYNOTE-024: Unlocking a pathway to lung cancer cure?

Journal Article

Rusch, V. W.; Chaft, J.; Hellmann, M.
Journal of Thoracic and Cardiovascular Surgery (2018)

Fulltext@MSK | Save

Identifying the optimal radiation dose in locally advanced non-small-cell lung cancer treated with definitive radiotherapy without concurrent chemotherapy

Journal Article

Sonnick, M. A.; Oro, F.; Yan, B.; Desai, A.; Wu, A. J.; Shi, W.; Zhang, Z.; Gelblum, D. Y.; Paik, P. K.; Yorke, E. D.; more...
Clinical Lung Cancer (2018)

Fulltext@MSK | Save

Liquid biopsy for ctDNA to revolutionize the care of patients with early stage lung cancers

Journal Article

Li, B. T.; Stephens, D.; Chaft, J. E.; Rudin, C. M.; Jones, D. R.; Rusch, V. W.; Rimner, A.; Isbell, J. M.
Annals of Translational Medicine (2017)

Fulltext@MSK | Save

Phase II trial of atezolizumab as first-line or subsequent therapy for patients with programmed death-ligand 1-selected advanced non-small-cell lung cancer (BIRCH)